日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD): A Pilot Clinical Trial

利用衰老细胞清除疗法调节阿尔茨海默病进展(SToMP-AD):一项初步临床试验

Gonzales, M M; Garbarino, V R; Marques Zilli, E; Petersen, R C; Kirkland, J L; Tchkonia, T; Musi, N; Seshadri, S; Craft, S; Orr, M E

Cellular Senescence in Idiopathic Pulmonary Fibrosis

特发性肺纤维化中的细胞衰老

Kellogg, D L; Kellogg, D L Jr; Musi, N; Nambiar, A M

The effect of muraglitazar on adiponectin signalling, mitochondrial function and fat oxidation genes in human skeletal muscle in vivo

穆拉格列扎对人体骨骼肌中脂联素信号传导、线粒体功能和脂肪氧化基因的影响

Coletta, D K; Fernandez, M; Cersosimo, E; Gastaldelli, A; Musi, N; DeFronzo, R A

Insulin stimulation regulates AS160 and TBC1D1 phosphorylation sites in human skeletal muscle

胰岛素刺激调节人骨骼肌中AS160和TBC1D1的磷酸化位点

Middelbeek, R J W; Chambers, M A; Tantiwong, P; Treebak, J T; An, D; Hirshman, M F; Musi, N; Goodyear, L J

Critical role of chemokine (C-C motif) receptor 2 (CCR2) in the KKAy + Apoe -/- mouse model of the metabolic syndrome

趋化因子(CC基序)受体2(CCR2)在KKAy+Apoe-/-代谢综合征小鼠模型中的关键作用

Martinez, H G; Quinones, M P; Jimenez, F; Estrada, C A; Clark, K; Muscogiuri, G; Sorice, G; Musi, N; Reddick, R L; Ahuja, S S

Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects

胰岛素和口服降糖药对2型糖尿病患者葡萄糖代谢、血管功能障碍和骨骼肌炎症的影响

Joya-Galeana, J; Fernandez, M; Cervera, A; Reyna, S; Ghosh, S; Triplitt, C; Musi, N; DeFronzo, R A; Cersosimo, E

Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial

吡格列酮可刺激AMP激活蛋白激酶信号通路,并增加人体骨骼肌中参与脂联素信号通路、线粒体功能和脂肪氧化的基因表达:一项随机试验

Coletta, D K; Sriwijitkamol, A; Wajcberg, E; Tantiwong, P; Li, M; Prentki, M; Madiraju, M; Jenkinson, C P; Cersosimo, E; Musi, N; Defronzo, R A

Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans.

肥胖型 2 糖尿病患者骨骼肌中 TNF-α 转化酶/金属蛋白酶组织抑制剂 3 蛋白水解系统的调节受损:人类胰岛素抵抗的新机制

Monroy A, Kamath S, Chavez A O, Centonze V E, Veerasamy M, Barrentine A, Wewer J J, Coletta D K, Jenkinson C, Jhingan R M, Smokler D, Reyna S, Musi N, Khokka R, Federici M, Tripathy D, DeFronzo R A, Folli F